PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $891,100 | -22.0% | 338,821 | +4.7% | 0.00% | – |
| Q2 2023 | $1,142,319 | +8.8% | 323,603 | -4.8% | 0.00% | – |
| Q1 2023 | $1,050,275 | -50.1% | 339,895 | -31.7% | 0.00% | – |
| Q4 2022 | $2,105,300 | +126.9% | 497,707 | +27.1% | 0.00% | – |
| Q3 2022 | $928,000 | -21.8% | 391,522 | -6.0% | 0.00% | – |
| Q2 2022 | $1,186,000 | +102.4% | 416,464 | +104.6% | 0.00% | – |
| Q1 2022 | $586,000 | -30.9% | 203,520 | -27.0% | 0.00% | – |
| Q4 2021 | $848,000 | -47.2% | 278,964 | +21.7% | 0.00% | – |
| Q3 2021 | $1,607,000 | -19.3% | 229,255 | +5.7% | 0.00% | – |
| Q2 2021 | $1,992,000 | +458.0% | 216,951 | +490.3% | 0.00% | – |
| Q1 2021 | $357,000 | -93.0% | 36,751 | -92.6% | 0.00% | -100.0% |
| Q4 2020 | $5,121,000 | +264.2% | 499,112 | +258.1% | 0.00% | – |
| Q3 2020 | $1,406,000 | +191.7% | 139,397 | +201.7% | 0.00% | – |
| Q2 2020 | $482,000 | -22.1% | 46,199 | -37.0% | 0.00% | – |
| Q1 2020 | $619,000 | -54.0% | 73,305 | -52.3% | 0.00% | – |
| Q4 2019 | $1,346,000 | -75.4% | 153,839 | -69.7% | 0.00% | -100.0% |
| Q3 2019 | $5,471,000 | -11.7% | 508,198 | +4.3% | 0.00% | -50.0% |
| Q2 2019 | $6,194,000 | +22.4% | 487,392 | +273.6% | 0.00% | +100.0% |
| Q1 2019 | $5,060,000 | +384.2% | 130,443 | +154.1% | 0.00% | – |
| Q4 2018 | $1,045,000 | -67.4% | 51,345 | -26.6% | 0.00% | -100.0% |
| Q3 2018 | $3,205,000 | -58.7% | 69,912 | -46.7% | 0.00% | -50.0% |
| Q2 2018 | $7,763,000 | +28.0% | 131,256 | +47.3% | 0.00% | 0.0% |
| Q1 2018 | $6,065,000 | -72.5% | 89,111 | -60.1% | 0.00% | -66.7% |
| Q4 2017 | $22,069,000 | +210.5% | 223,257 | +276.2% | 0.01% | +200.0% |
| Q3 2017 | $7,107,000 | +63.2% | 59,351 | +19.1% | 0.00% | +100.0% |
| Q2 2017 | $4,355,000 | -23.8% | 49,832 | -67.6% | 0.00% | 0.0% |
| Q1 2017 | $5,718,000 | -82.2% | 153,704 | -85.3% | 0.00% | -80.0% |
| Q4 2016 | $32,058,000 | +271.0% | 1,044,192 | +710.1% | 0.01% | +66.7% |
| Q3 2016 | $8,642,000 | +1905.1% | 128,889 | +790.3% | 0.00% | – |
| Q2 2016 | $431,000 | -71.9% | 14,477 | -72.3% | 0.00% | -100.0% |
| Q1 2016 | $1,534,000 | -8.6% | 52,213 | +143.8% | 0.00% | 0.0% |
| Q4 2015 | $1,679,000 | +3.6% | 21,420 | -0.3% | 0.00% | 0.0% |
| Q3 2015 | $1,621,000 | -23.6% | 21,492 | +18.2% | 0.00% | 0.0% |
| Q2 2015 | $2,123,000 | +2.6% | 18,189 | +107.6% | 0.00% | 0.0% |
| Q1 2015 | $2,069,000 | +28.2% | 8,760 | +2.7% | 0.00% | 0.0% |
| Q4 2014 | $1,614,000 | -2.5% | 8,531 | +22.9% | 0.00% | 0.0% |
| Q3 2014 | $1,655,000 | +7.5% | 6,940 | -70.2% | 0.00% | 0.0% |
| Q2 2014 | $1,539,000 | -14.2% | 23,310 | +35.3% | 0.00% | 0.0% |
| Q1 2014 | $1,794,000 | +163.4% | 17,225 | +161.9% | 0.00% | – |
| Q4 2013 | $681,000 | +225.8% | 6,578 | +68.9% | 0.00% | – |
| Q3 2013 | $209,000 | -75.2% | 3,894 | -79.5% | 0.00% | – |
| Q2 2013 | $842,000 | – | 18,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |